Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cian Healthcare Ltd's Board of Directors, at a meeting held on March 16, 2026, approved a revised version (Version 2.0) of its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information. This filing has been made to BSE under Regulation 8(2) of SEBI's Insider Trading Regulations, 2015, and the revised code is effective from March 16, 2026. The updated code outlines how the company will handle and disclose price-sensitive information, defines who counts as an 'insider' or 'designated person,' and sets rules on legitimate sharing of such information. It also establishes the Company Secretary as the Chief Investor Relations Officer (CIRO) and requires a structured digital database to track sharing of sensitive information.
This is a routine regulatory and corporate governance update with no direct impact on the company's financials, operations, or stock price. It reinforces transparency and insider trading controls, which is positive for governance standards but not a catalyst for the share price.